From a controlled laboratory environment in the United States, AMNO Labs was founded on a single non-negotiable principle: every peptide must meet the highest standard of purity and be verified through independent U.S. analytical testing.

We source high grade amino acid inputs and manufacture under stringent ISO aligned protocols.

Each production lot undergoes orthogonal analytical validation using high performance liquid chromatography (HPLC) alongside mass spectrometry to confirm both purity and molecular identity. Independent U.S. laboratories also verify net peptide content, ensuring every vial meets or exceeds its labeled milligram quantity.

Only batches documenting ≥99% purity and confirmed molecular identity are released under the AMNO label. Every vial carries a unique lot number, enabling researchers to access complete third-party test results directly through our verification portal.

This commitment to measurable, transparent quality defines how AMNO scales. From 5 mg and 10 mg research formats to expanded production supporting multisite research programs, each order reflects our core standard: U.S. verified, analytically confirmed, uncompromisingly pure. By continually investing in advanced analytical capabilities and maintaining strict chain of custody controls, AMNO Labs ensures researchers receive peptides they can trust now and for every discovery ahead.